Related Experiment Video

Updated: May 17, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Silymarin for diabetic nephropathy: the challenges of botanical product research

Catherine M Meyers, Josephine P Briggs

    American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
    |November 13, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Preparation of Naringenin Solution for In Vivo Application
    08:18

    Preparation of Naringenin Solution for In Vivo Application

    Published on: August 10, 2021

    Related Experiment Videos

    Last Updated: May 17, 2026

    Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
    08:15

    Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

    Published on: May 10, 2024

    Preparation of Naringenin Solution for In Vivo Application
    08:18

    Preparation of Naringenin Solution for In Vivo Application

    Published on: August 10, 2021

    Related Concept Videos

    Diabetic Nephropathy01:28

    Diabetic Nephropathy

    Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

    Articles linked to this work by shared authors, journal, and citation graph.

    Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies.

    Healthcare (Amsterdam, Netherlands)·2021

    Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

    Kidney international·2020

    Addressing guideline and policy changes during pragmatic clinical trials.

    Clinical trials (London, England)·2019

    Models and Studies of Aging: Executive Summary of a Report from the U13 Conference Series.

    Journal of the American Geriatrics Society·2019

    Pragmatic clinical trials offer unique opportunities for disseminating, implementing, and sustaining evidence-based practices into clinical care: Proceedings of a workshop.

    Healthcare (Amsterdam, Netherlands)·2018

    The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

    Neurology·2017

    Application of a Kidney Hierarchical Composite Endpoints in Trials of CKD Progression: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    A Perspective on the Role of Nephrologists in the Cardio-Kidney-Metabolic Syndrome.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    The 'Known Unknowns' of CKD of Undetermined Etiology In 2026.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    Approach to Hematuria: Core Curriculum 2026.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    Self-Reported Versus Performance-Based Measures of Physical Function and Mortality Among Patients With Kidney Failure: A Cohort Analysis of the CONVINCE Trial.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

    [Retracted] In vitro modulation of MMP‑2 and MMP‑9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.

    International journal of oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us